... >
organooxygen compound >
ester >
carboxylic ester >
lactone >
cyclodepsipeptide >
(3r,10s,13s,16s,19s)-16-[(2r)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
... >
organooxygen compound >
carbonyl compound >
carboxylic ester >
lactone >
cyclodepsipeptide >
(3r,10s,13s,16s,19s)-16-[(2r)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
organooxygen compound >
ester >
lactone >
cyclodepsipeptide >
(3r,10s,13s,16s,19s)-16-[(2r)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
organonitrogen compound >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
(3r,10s,13s,16s,19s)-16-[(2r)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
... >
organooxygen compound >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
(3r,10s,13s,16s,19s)-16-[(2r)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
amide >
primary amide >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
(3r,10s,13s,16s,19s)-16-[(2r)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic amino compound >
peptide >
depsipeptide >
cyclodepsipeptide >
(3r,10s,13s,16s,19s)-16-[(2r)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
organonitrogen compound >
organic amino compound >
peptide >
depsipeptide >
cyclodepsipeptide >
(3r,10s,13s,16s,19s)-16-[(2r)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
اصطلاح مرجح
(3r,10s,13s,16s,19s)-16-[(2r)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
اینچی
-
InChI=1S/C29H48ClN5O8/c1-8-17(4)23-28(41)34(7)24(16(2)3)29(42)33(6)18(5)25(38)31-12-11-22(37)43-21(14-19(36)15-30)27(40)35-13-9-10-20(35)26(39)32-23/h16-21,23-24,36H,8-15H2,1-7H3,(H,31,38)(H,32,39)/t17-,18+,19?,20+,21-,23+,24+/m1/s1
اینچیکی
-
WUTLOXOGFQPKLT-TURBSJQQSA-N
اسمایلٓ
-
ClCC(O)C[C@H]1OC(=O)CCNC(=O)[C@@H](N(C(=O)[C@@H](N(C(=O)[C@@](NC(=O)[C@]2(N(CCC2)C1=O)[H])([C@@H](CC)C)[H])C)C(C)C)C)C
مترادف دقیق
-
(3R,10S,13S,16S,19S)-16-[(2R)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
-
(3R,10S,13S,16S,19S) 16 [(2R) butan 2 yl] 3 (3 chloro 2 hydroxypropyl) 10,11,14 تری متیل 13 پروپان 2 yl 4 oxa 1,8,11,14,17[17co. 2،5،9،12،15،18 هگزون
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:182855